Engineering cellular biology, minus the actual cell, is a growing area of interest in biotechnology and synthetic biology. It’s known as cell-free protein synthesis, or CFPS, and it has potential to provide sustainable ways to make chemicals, medicines and biomaterials.
Unfortunately, a long-standing gap in cell-free systems is the ability to manufacture glycosylated proteins – proteins with a carbohydrate attachment. Glycosylation is crucial for a wide range of important biological processes, and the ability to understand and control this mechanism is vital for disease treatment and prevention.
Matthew DeLisa, the William L. Lewis Professor of Engineering in the Smith School of Chemical and Biomolecular Engineering, and Michael Jewett, associate professor of chemical and biological engineering at Northwestern University, have teamed up on a novel approach that bridges this gap. Their system, the first of its kind, capitalizes on the recent advances in CFPS while adding the crucial glycosylation component in a simplified, “one-pot” reaction. In the future, their cell-free glycoprotein synthesis system could be freeze-dried and reactivated for point-of-use protein synthesis by simply adding water.
DeLisa and Jewett are co-senior authors of “Single-pot Glycoprotein Biosynthesis Using a Cell-Free Transcription-Translation System Enriched with Glycosylation Machinery,” published July 12 in Nature Communications.
Thapakorn Jaroentomeechai, Ph.D. student in the DeLisa Research Group, and Jessica Stark ’12, Ph.D. student in the Jewett group, are co-first authors.
“If you really want to have a useful, portable and deployable vaccine or therapeutic protein technology that’s cell free, you have to figure out the carbohydrate attachment,” DeLisa said. “That’s, in essence, what we’ve done in a very powerful way.”
This work could impact development of decentralized manufacturing strategies. Rapid access to protein-based medicines in remote settings could change lives; new biomanufacturing paradigms suitable for use in low-resource settings might promote better access to costly drugs through local, small-batch production.
DeLisa has done a great deal of research on the molecular mechanisms underlying protein biogenesis in the complex environment of a living cell, such as Escherichia coli (E. coli). While his lab has made some notable breakthroughs, the limitations of this area, he said, are the cell walls themselves.
Jewett’s lab at Northwestern has invested much of its research efforts into cell-free synthetic biology, which leverages nature’s most elegant biomachinery outside the confines of the cell, so a collaboration was a natural extension of both labs’ work.
“In bacterial cell engineering, you’re constantly in a tug of war,” Jewett said. “You’re introducing a mechanism or capability that’s of interest to you as a scientist, but what the cell is trying to do for itself is grow and survive.”
For their new method, the team prepared cell extracts from an optimized laboratory strain of E. coli, CLM24, that were selectively enriched with key glycosylation components. The resulting extracts enabled a simplified reaction scheme, which the team has dubbed cell-free glycoprotein synthesis (CFGpS).
“A major advance of this work is that our cell-free extracts contain all of the molecular machinery for protein synthesis and protein glycosylation,” Stark said. “What that means is you only need to add DNA instructions for your protein of interest to make a glycoprotein in CFGpS. This is a drastic simplification from cell-based methods and allows us to make sophisticated glycoprotein molecules in less than a day.”
And the CFGpS method is highly modular, allowing for the use of distinct and diverse extracts to be mixed for the production of a variety of glycoproteins.
“Because we chose E. coli, which lacks its own glycosylation machinery, to build our CFGpS platform, it gave us a blank slate for bottom-up engineering of any desired glycosylation system,” Jaroentomeechai said. “This gives us the unique ability to control carbohydrate structures and purities of the glycoproteins at levels that are not currently achievable in other cell-based expression systems.”
Even in developed countries like the U.S., the move toward personalized medicine makes this type of on-demand drug production protocol attractive. “You could use a test tube instead of a 50,000-liter bioreactor to make your product, which opens the door to a personalized biomanufacturing paradigm where each patient can receive a unique protein medicine tailored to their physiology,” he said.
The Latest on: Personalized biomanufacturing
[google_news title=”” keyword=”personalized biomanufacturing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Personalized biomanufacturing
- Liberation Labs Selects Indiana for First Biomanufacturing Facilityon January 24, 2023 at 4:09 am
Jan. 24, 2023 (GLOBE NEWSWIRE) -- Liberation Labs, a large-scale precision fermentation manufacturer, has executed a purchase agreement for the site of its first commercial-scale biomanufacturing ...
- 23 best personalized Valentine's Day gift ideas for incredibly picky men & womenon January 23, 2023 at 2:20 pm
As a shopping editor, I see a lot of stuff; therefore, I can tell you from a professional (and personal) standpoint — there is nothing better than a personalized gift. Speaking for myself, I am very ...
- Picking a personalized license plate in IL? Here are some of the prohibited phraseson January 23, 2023 at 11:16 am
The Illinois Secretary of State’s office maintains a list of more than 7,000 rejected requests for personalized and vanity license plates. Provided If you’re opting to pay extra for a ...
- The Canadian Alliance for Skills and Training in Life Sciences (CASTL) announces location for Quebec Biomanufacturing Training Facilityon January 23, 2023 at 10:57 am
The Canadian Alliance for Skills and Training in Life Sciences (CASTL) announced today its expansion into Quebec with the location of their future Biomanufacturing Training Facility in Montreal.
- 39 Personalized Gifts That Show How Much You Careon January 22, 2023 at 4:00 pm
Ratings and prices are accurate and items are in stock as of time of publication. Among the best personalized gift ideas is this classic nameplate necklace, which gets a modern upgrade with ...
- GMP Plasmid DNA Manufacturing Market Market Size 2023 Industry Analysis, Key Players, Regional Demand, Opportunity and Forecast 2028on January 22, 2023 at 4:00 pm
Global main GMP Plasmid DNA Manufacturing players cover Thermo Fisher Scientific, Cobra Bio, GenScript ProBio, WuXi Advanced Therapies, Charles River, Waisman Biomanufacturing ... This drives us to ...
- As Cell Therapy Gains Ground, Efforts Emerge to Improve CAR T-Manufacturingon January 19, 2023 at 7:07 am
Cell therapy offers a treatment option for some advanced blood cancers, but the manufacturing process is lengthy and complex. The biopharmaceutical industry is working on various technologies that ...
- Can BiologIC’s Biocomputer Help Bring Biomanufacturing To Space?on January 18, 2023 at 4:00 pm
manufactures custom-made parts using 3D printing, and combines them into one integrated system. The result is the most simple yet versatile biomanufacturing system in the world: the device can ...
- Personalized Medicine Sector Needs to Consider Environmental Impacton January 18, 2023 at 7:39 am
Advanced technologies can help personalized medicine firms minimize their environmental impact, but only if used as part of a strategic plan that takes all aspects of production, storage ...
via Bing News